Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled elective Total Knee Arthroplasty (TKA) under spinal anesthesia~* Aged 18-80 years old~* ASA physical class 1, 2, or 3~* BMI \</= 42 kg/m2~* Generally healthy~Exclusion Criteria:~* Concurrent condition requiring analgesic treatment during study period~* Opioid tolerant~* Known allergy to capsaicin or other study medication~* Use of prohibited medications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- CA-008 36 mg (Type: ACTIVE_COMPARATOR): Single administration (0.3 mg/mL concentration)
- CA-008 60 mg (Type: ACTIVE_COMPARATOR): Single administration (0.5 mg/mL concentration)
- CA-008 90 mg (Type: ACTIVE_COMPARATOR): Single administration (0.75 mg/mL concentration)
- Placebo (Type: PLACEBO_COMPARATOR): Single administration

Based on this trial design, predict the completion outcome and termination type (if applicable).